data

How 24/7 self-scheduling can improve the post-pandemic patient experience

This is the second in a series of blog posts that will highlight how the patient journey has evolved since the onset of COVID-19. This series will take you through the changes that impacted every step of the patient journey and provide strategic recommendations to move forward. In this post, we explore how 24/7 self-scheduling can …

How 24/7 self-scheduling can improve the post-pandemic patient experience Read More »

Should we do away with ACOs? The answer depends on who you ask  

In a new study, researchers suggest ACOs are not helping CMS save substantial amounts of money as they were expected to do, so the model should be eliminated. But other experts in the industry disagree, taking issue with the study’s methods and conclusions.

How COVID-19 changed the patient journey: A call for digital transformation

COVID-19 changed every aspect of the patient journey – placing unprecedented demands on the healthcare system and accelerating the need for digital transformation industry-wide. Telehealth, touchless engagement, and self-service scheduling became the new normal; however, this created new stress on operations, administration, and finance. While this new normal comes with many challenges, data and digital …

How COVID-19 changed the patient journey: A call for digital transformation Read More »

How data standardization can improve patient outcomes

Patchy patient data has plagued the healthcare industry for decades, but the pandemic opened the door to a whole new set of identity management challenges. As patients rushed to register for patient portals and book vaccines, many unwittingly created multiple accounts, having forgotten they’d already signed up. Fluctuating unemployment levels meant many individuals were forced …

How data standardization can improve patient outcomes Read More »

Analysis: Care for the unvaccinated may be costing U.S. healthcare system $2.3B

The report, released by Kaiser Family Foundation and the Peterson Center on Healthcare, details the high cost of Covid care for the unvaccinated. In fact, the analysis indicates the figure could be even higher than $2.3 billion, as the authors did not take into account the cost of outpatient treatment for Covid-19.

The State of Patient Access 2.0: 4 opportunities to strengthen the digital experience

“93% of providers say creating a better patient experience remains a top priority, up 3% from last year.” – Experian Health’s State of Patient Access, June 2021 Download now In November 2020, we surveyed patients and providers for their sentiments on how patient access changed because of the pandemic. During this time, patients welcomed the …

The State of Patient Access 2.0: 4 opportunities to strengthen the digital experience Read More »

As work went remote, cybersecurity teams doubled down on clear communication, flexibility

In a remote work environment, cybersecurity teams learned that they needed to support their organizations by providing workers with the information they needed to secure their data, while also remaining flexible to changing needs, panelists said at a HIMSS Digital session.

Accelerating synthetic chemistry with a predictive retrosynthesis solution

In most aspects of life, we think of “endless possibilities” as a good thing. But in science, the wealth of possibilities can be daunting. Pharmaceutical researchers typically start with a disease that they want to tackle, find a target, and then try to identify compounds which interact with that target. There may be around 200-300 …

Accelerating synthetic chemistry with a predictive retrosynthesis solution Read More »

Widespread use of health IT can cause burnout but also help curb it

In a HIMSS 21 Digital session, panelists detailed the dichotomy of technology advancement for clinicians. Though technology has made it harder for them to disconnect from work leading to burnout, IT tools can also be used to identify pain points and implement solutions to alleviate stress.

Boost vaccination rates with frictionless self-scheduling

It’s time to accelerate the pace of COVID-19 vaccinations. Healthcare experts are increasingly concerned about the rapid spread of the highly contagious delta variant, which now makes up over 83% of COVID-19 cases. This variant is estimated to be 60% more transmissible than previous strains, and while vaccination doesn’t eliminate the risk, it does reduce …

Boost vaccination rates with frictionless self-scheduling Read More »

Boost vaccination rates with frictionless self-scheduling

As the country strives to ramp up the pace of COVID-19 vaccinations, providers need to take new approaches to drive registration volume. Healthcare experts are increasingly concerned about the rapid spread of the highly contagious delta variant, which now makes up over 83% of COVID-19 cases. This variant is estimated to be 60% more transmissible …

Boost vaccination rates with frictionless self-scheduling Read More »

Self-service patient registration isn’t just for the pandemic

Consumer-led care hit its stride during the pandemic. COVID-19 unlocked healthcare’s digital front door, giving patients more control over how and when they schedule and manage appointments. Unfortunately, while digital patient access has made navigating the healthcare system more convenient and flexible in many ways, consumers are discovering that one of the more frustrating aspects …

Self-service patient registration isn’t just for the pandemic Read More »

Bon Secours Mercy Health invests in Trilliant Health as part of larger push into analytics

The health system has invested an undisclosed amount in Trilliant Health, which provides a predictive analytics platform giving users insights into market dynamics. Bon Secours Mercy Health is also a founding member of another healthcare data company: Truveta.

ViewPoints Interview: Janssen’s Jan Wehkamp and Icahn School of Medicine’s Dr. Bruce Sands Share Insights on the Data Presented at DDW 2021

In an interview with PharmaShots, Jan Wehkamp, M.D., Vice President, Gastroenterology Disease Area Leader at Janssen, and Bruce Sands, Dr. Burrill B. Crohn Professor of Medicine at the Icahn School of Medicine share their views on the data of Stelara and Tremfya presented at DDW 2021. Shots: Janssen presented the new data on Stelara (ustekinumab) …

ViewPoints Interview: Janssen’s Jan Wehkamp and Icahn School of Medicine’s Dr. Bruce Sands Share Insights on the Data Presented at DDW 2021 Read More »

Interoperability now needs to go beyond EHRs to include the larger digital health ecosystem

The next step in the evolution of interoperability will involve examining data flows in digital healthcare, according to panelists at the American Telemedicine Association’s annual conference. This includes looking into how data sharing will support telehealth, remote patient monitoring and programs involving wearables.

Confronting the Problem of AI Bias

When thinking of artificial intelligence (AI), many people rely on cultural touchstones from science fiction films and TV. They might think of HAL, the calm-voiced AI from 2001: A Space Odyssey, or Data, the even-tempered android from Star Trek. We tend to imagine that artificial intelligence will be driven by reason, logic and facts – …

Confronting the Problem of AI Bias Read More »

Clinical trials are undergoing a sea change thanks to telehealth, advanced data solutions

The clinical trial arena is changing rapidly, driven largely by the acceleration of telehealth usage and the potential provided by new data solutions. Panelists at MedCity INVEST Precision Medicine agreed that clinical trials will never be conducted in the same way again.

UPMC spins out AI-driven analytics company focused on chronic disease patients

Realyze Intelligence, incubated at and funded by UPMC Enterprises, provides a platform that uses EMR data to identify chronic disease patients and help clinicians link them to appropriate treatment options. The platform leverages not only the structured data available in EMRs but also unstructured clinical notes.

Where 5 CIOs see IT innovation heading as pandemic winds down  

The Covid-19 pandemic has upended the healthcare industry in a myriad of ways — including the focus of IT innovation. Healthcare CIOs are seeing IT innovation priorities shift to arenas like at-home care, data science and supply chain.

Anthem, Epic strike data exchange partnership

The EHR giant will integrate its payer platform with the insurer’s operating system to facilitate two-way data exchange with providers. Through this integration, the organizations hope to support clinical decision-making and streamline administrative processes like prior authorizations.

Key insights for a successful first-time product launch

Pre-commercial & Emerging pharma companies may not think they have the resources to match the launch strategies of big pharma. But with the proper planning and an agile approach, they can be more successful than they realise, says Veeva’s Ian Hale. He takes us through the challenges of a successful launch and explains what pre-commercial …

Key insights for a successful first-time product launch Read More »

Guidance on use of real-world evidence for devices and diagnostics

Real-world evidence is often used to assess the safety of devices and diagnostics. For instance, the FDA’s , Postmarketing Surveillance Program includes the FDA Adverse Event Reporting System (FAERS); FDA may also require some MedTech companies to conduct Post-Approval Studies. However, as new legislation (e.g., 21st Century Cures Act) has passed and new technology has …

Guidance on use of real-world evidence for devices and diagnostics Read More »

Blue Health Intelligence, AnalyticsIQ to help fight health inequity by enhancing payer data

Together, the companies will add race, ethnicity and language information as well as social determinants of health factors to a database of millions of Blues plan members. The insights gleaned will be used to design interventions and develop community partnerships to reduce disparities in care.

Some proposed HIPAA changes could inadvertently expose the data it’s supposed to protect

The government’s proposed changes to HIPAA aim to provide guardrails against data breaches and misuse, but some of the modifications may not work as intended. Three healthcare experts delved into the ways in which certain proposals could provide inappropriate access to health data during a recent panel discussion.

COVID heralds a faster future for drug development (if stakeholders can collaborate)

COVID-19 has been a trial-by-fire showing just how quickly drugs and vaccines can be developed under the right circumstances – but there is much to do to ensure this progress is not lost, said speakers at WIRED Health 2021, including the CEOs of BioNTech and BenevolentAI.  The 2021 WIRED Health conference took a broad view …

COVID heralds a faster future for drug development (if stakeholders can collaborate) Read More »

Jean Drouin, Clarify Health, on the new data stack.

By MATTHEW HOLT Clarify Health has linked (but anonymized) data on about 300m Americans, including their claims, lab, (some) EMR data and their SDOH data. They then use it to help providers, plans and pharma figure out what is going on with their patients, and how their doctors et al are behaving. CEO Jean Drouin, …

Jean Drouin, Clarify Health, on the new data stack. Read More »

FDA Introduces Data Modernization Action Plan

One of the frustrations of our Big Data era is that, despite the existence of an ever-growing wealth of valuable data, this data is often stuck in different silos. This lack of accessibility makes it hard to get the most out of data that has the potential to be extremely useful. The United States really …

FDA Introduces Data Modernization Action Plan Read More »

Life sciences must become cloud-first to seize the science of tomorrow

If the power of the life sciences industry to innovate and collaborate were ever in doubt, the speed at which vaccines for COVID-19 were discovered, developed, trialled, approved and manufactured have confirmed just how dynamic the industry can be. And that dynamism, innovation and collaboration are all qualities that the industry must continue to nurture …

Life sciences must become cloud-first to seize the science of tomorrow Read More »

How UCSF created a data platform that leverages 150+ social determinants variables

UCSF’s interactive data platform allows users to drill down into 150 social determinants of health variables. This data, layered with EHR data, can give researchers and clinicians invaluable insights into the nexus of social factors and health.

ViewPoints Interview: Legend’s Ying Huang Shares Insight on ASH 2020 Data and Initiation of BLA Rolling Submission for Cilta-cel

In an interview with PharmaShots, Ying Huang, Ph.D., CEO and CFO of Legend Biotech shed light on the clinical data following the rolling submission of BLA for Cilta-cel. He also shared insight on Legends’ collaboration with Janssen. Shots: The submission of BLA was based on results from the P-Ib/II CARTITUDE-1 study of cilta-cel, which were …

ViewPoints Interview: Legend’s Ying Huang Shares Insight on ASH 2020 Data and Initiation of BLA Rolling Submission for Cilta-cel Read More »

Use of real-world evidence for regulatory decision-making

How do you evaluate treatment efficacy and safety outside of the clinical trial setting? This is not just a question of academic interest. In last week’s JAMA, Rubin 2021 writes about some of the challenges of evaluating COVID-19 vaccines outside of a clinical trial setting. In an interesting, two-day workshop last week, the Duke Margolis …

Use of real-world evidence for regulatory decision-making Read More »

Cerner, Philips invest in Carevive Systems’ oversubscribed $18M equity round

The health technology company will use the investment to deploy its cancer care management platform and remote monitoring program at more health systems and to advance its research capabilities. Philips Health Technology Ventures led the equity round, and Cerner was a returning investor.

ViewPoints Interview: Deciphera’s Mathew L. Sherman Shares Insight on Data of QINLOCK and DCC-3014 Presented at CTOS 2020

In an interview with PharmaShots, Matthew L. Sherman, M.D., Executive Vice President and Chief Medical Officer of Deciphera shed light on encouraging preliminary results from the ongoing P-I/II study of DCC-3014 in TGCT patients and also presented the data of QINLOCK at CTOS 2020 Shots: Deciphera presented encouraging preliminary results from the ongoing Phase 1/2 …

ViewPoints Interview: Deciphera’s Mathew L. Sherman Shares Insight on Data of QINLOCK and DCC-3014 Presented at CTOS 2020 Read More »

14 major health systems launch data insights company

In an unusual move, 14 major providers — including Trinity Health, CommonSpirit Health and Tenet — have come together to launch a data analytics company. Insights derived from the company’s platform will be available to providers, biopharma companies and scientific researchers working to advance patient care.

Kaiser Permanente joins forces with Accenture, Microsoft to improve cloud capabilities

The California-based healthcare organization will work with Accenture and Microsoft to grow and strengthen its cloud capabilities. The enhancements are expected to help Kaiser provide its care teams with data insights to personalize patient care.

Real-world evidence: breaking boundaries in rare disease

The COVID-19 pandemic has added a new layer of complexity to the drug development process. Launch timelines have been delayed and clinical trials have been postponed or suspended. As a result, life sciences companies are turning to novel methods of collecting clinical data and innovative trial design. The generation of data to show the significant …

Real-world evidence: breaking boundaries in rare disease Read More »

A collaborative approach to greater diversity in clinical trials

The need for diversity in clinical trial populations has been a topic of discussion across regulators and the industry in general for decades. Despite the introduction of US policies, beginning with the 1993 National Institutes of Health (NIH) Revitalization Act which called for the inclusion of more women and communities of colour in clinical trials, …

A collaborative approach to greater diversity in clinical trials Read More »

ViewPoints Interview: Janssen’s Andrew Greenspan Shares Insights on the Data Presented at ACR2020

In a recent interview with PharmaShots, Andrew Greenspan, MD, VP Medical Affairs of Janssen Immunology shared his views on Janssen’s commitment to advance research in rheumatic disease. Shots: Janssen presented clinical trial results in 35 abstracts featuring findings across PsA, RA, and SLE at ACR Convergence 2020 Virtual Scientific Program Sixteen abstracts focus on Tremfya …

ViewPoints Interview: Janssen’s Andrew Greenspan Shares Insights on the Data Presented at ACR2020 Read More »

True patient-focused research through decentralised and hybrid trials

How can pharma improve the patient-centricity of its trials during COVID-19 and beyond? Experts from across the sector give their thoughts on the key approaches and technologies that are driving patient engagement forward. With COVID-19 presenting new barriers to running and recruiting for clinical trials, making studies patient-centric is more important now than ever before. …

True patient-focused research through decentralised and hybrid trials Read More »

Elsevier to Work with Heel for Mechanism-based Drug Action Discovery

Elsevier, the data analytics business specialized in science and health, and Heel, a pharmaceutical company specialized in developing and manufacturing medicines made from natural ingredients, have recently completed a series of research projects with a focus on improving exploratory preclinical studies. “We at Heel are pioneers in the field of systems research and have a …

Elsevier to Work with Heel for Mechanism-based Drug Action Discovery Read More »

Behind the scenes: How health systems, EHR vendors will give patients unprecedented access to their data

Health systems and EHR vendors have been working for months to comply with the ONC’s final rule on interoperability and information blocking that goes into effect in April and is expected to grant patients unprecedented access to their health information. Here is a look at some of the issues they contended with.

Zydus Cadila Seeks Approval to Commence P-III Clinical Study of ZyCoV-D

Shots: The company reported that the COVID-19 vaccine is safe, well-tolerated & immunogenic in the P-I/II study & plans to initiate P-III clinical trial in ~30000 volunteers upon receiving necessary approvals The P-II study of ZyCoV-D had been conducted in ~1000 healthy adult volunteers as part of the adaptive P-I/II dose-escalation study The trial has …

Zydus Cadila Seeks Approval to Commence P-III Clinical Study of ZyCoV-D Read More »

Regeneron’s Antibody Cocktail Demonstrate Promising Results in Hospitalized Patients on Low-Flow Oxygen

Shots: The company reported encouraging initial data from an ongoing P-I/II/III trial of its casirivimab + imdevimab (8,000/2,400mg) in hospitalized COVID-19 patients requiring low-flow oxygen. The results passed the futility analysis as seronegative patients treated with the Ab cocktail had a lower risk of death or receiving mechanical ventilation In seronegative patients, the cocktail reduced …

Regeneron’s Antibody Cocktail Demonstrate Promising Results in Hospitalized Patients on Low-Flow Oxygen Read More »

ViewPoints Interview: ViiV Healthcare’s Kimberly Smith Shares Insight on Data of Long-Acting Cabotegravir and Rilpivirine Presented at IDWeek 2020

In a recent interview with PharmaShots, Kimberly Smith, MD, MPH, Head of Research & Development at ViiV Healthcare shared information on the positive findings presented at the 2020 Infectious Diseases Society of America (IDWeek) and the impact of COVID-19 on the development of long-acting cabotegravir and rilpivirine. Shots: The company reported the positive findings of …

ViewPoints Interview: ViiV Healthcare’s Kimberly Smith Shares Insight on Data of Long-Acting Cabotegravir and Rilpivirine Presented at IDWeek 2020 Read More »

Cerner to snap up Kantar’s health division for $375M

The EHR giant is planning to buy Kantar Health, which provides data, analytics and research to the life sciences industry. Through the acquisition, Cerner aims to provide its clients with more access to data analytics and research expertise and engagement with life sciences companies.

Roche Highlights its Bispecific Antibody Portfolio Across a Range of Blood Cancers at ASH 2020

Shots: The company presented the new data of its T-cell engaging bispecific Abs, mosunetuzumab, glofitamab and cevostamab at ASH 2020, demonstrating encouraging activity across multiple types of blood cancer Roche divulges that its mosunetuzumab & glofitamab showed promising responses across multiple types of NHL, including R/R FL & DLBCL, reinforcing from the P-I/Ib GO29781 study …

Roche Highlights its Bispecific Antibody Portfolio Across a Range of Blood Cancers at ASH 2020 Read More »

DispatchHealth adds to evidence backing safety, efficacy of hospital-at-home programs

Amid the Covid-19 pandemic and a growing interest in at-home care, DispatchHealth has published new data showing that its hospital-at-home program did not result in unexpected deaths, serious adverse events or patients being subsequently admitted to a skilled nursing facility.

Dual Eligibles’ Medicaid Policy Database

Poor, elderly individuals who may qualify for both Medicaid (for being poor) and Medicare (for being elderly, blind, disabled or have ESRD). In these cases, Medicaid serves as a supplemental insurer, covering Medicare coinsurance and deductibles. The generosity of this supplemental coverage for so-called ‘dual-eligibles’ varies across states. These differences in Medicaid payments arise from …

Dual Eligibles’ Medicaid Policy Database Read More »

Takeda to partner on patient-centric data with Seqster

Takeda has partnered with patient data firm Seqster in a drive to improve care through better access and understanding of patient-level data. The partnership follows Takeda’s investment in the US startup earlier this year. The pharma firm said it wants to leverage the company’s technology across its business San Diego-based Seqster has developed a portal …

Takeda to partner on patient-centric data with Seqster Read More »

Dermavant Presents Results of Tapinarof in Pivotal P-III PSOARING Program at the 29th EADV Virtual Congress

Shots: The pivotal P-III clinical program for tapinarof in adult with PsO consists of PSOARING 1 (NCT03956355) and PSOARING 2 (NCT03983980) PSOARING 3 (NCT04053387), an ongoing long-term safety study. Positive results of P-III studies were reported in Aug’2020 Tapinarof previously met the 1EP in separate P-IIb trials for PsO & AD, both studies were published …

Dermavant Presents Results of Tapinarof in Pivotal P-III PSOARING Program at the 29th EADV Virtual Congress Read More »

Why 72% of patients don’t feel listened to by pharma

Claus Møldrup explores research showing that patients want their voice to be heard more by pharma, and asks what a truly effective feedback loop for medicines might look like. The democratisation of data opens up improvements to virtually every product and service across virtually every sector — bar one. Pharma remains stubbornly closed to feedback, …

Why 72% of patients don’t feel listened to by pharma Read More »

What can we learn from women’s health data?

Analysing real-world health data could help overcome the bias towards men in traditional medical research, says Sensyne Health’s Dr Lucy Mackillop. Collecting and analysing anonymised patient data has the potential to generate valuable insights that can catalyse research, lead to improved patient care, and power the development of new treatments. Being able to analyse large …

What can we learn from women’s health data? Read More »

Data hackathon analyses truth behind TB vaccine and COVID-19

Is a century-old vaccine a ‘game-changer’ for COVID-19? Anita de Waard from Elsevier and Radoslav Kirkov from Estafet tells us how a hackathon is harnessing data science to look beyond the hype and seek definitive clinical evidence. Today, the notion of ‘data science’ has permeated almost every area of society. Words like machine learning, artificial …

Data hackathon analyses truth behind TB vaccine and COVID-19 Read More »

How real human experiences can power a healthier future

As part of our series of opinion pieces from leaders at Janssen, the company’s Maria Raad looks at how we can embrace tech and data science to overcome increasing pressures on healthcare systems. For the next generation born in the western world, living to be the age of 100 will be the norm. While this …

How real human experiences can power a healthier future Read More »

Rare diseases, repurposing and the role of AI

In the age of artificial intelligence, no trial data should be going to waste. Findacure’s Rick Thompson looks at how these technologies could bring us closer to treatments for underserved rare diseases. The repurposing of drugs is becoming more common, especially in the field of rare diseases.  In the past, repurposing has mostly been driven …

Rare diseases, repurposing and the role of AI Read More »

J+D FORECASTING LAUNCHES INTELLIGENT DATA

J+D Forecasting, known as the experts in pharmaceutical forecasting, has today announced the launch of EpiCube; the latest addition to its comprehensive suite of pharmaceutical forecasting products. Unlike most standard epidemiological databases available, EpiCube is the first database where the user can choose how to build their own data set; be that by country, disease, …

J+D FORECASTING LAUNCHES INTELLIGENT DATA Read More »

Pharma’s digital transformation journey and the role of customer reference data

Better management of customer data could help pharmaceutical companies’ digital transformation, according to Veeva’s Rebecca Silver. pharmaphorum’s Richard Staines spoke to her about how the use of customer reference data can transform pharma companies, increase competitiveness, and benefit the bottom line during these challenging times. Precision medicine is emerging as a key approach for disease …

Pharma’s digital transformation journey and the role of customer reference data Read More »

The value of good data to patients

Better patient care pathways and models of care can be leveraged from the use of data, and the ability to collate and assess this information will drive more sustainable models of care, whilst unlocking the value of ‘longitudinal, real-world data’ as a resource for healthcare organisations, research and academia, policy advisors and pharma. There is …

The value of good data to patients Read More »

COVID-19 is Bringing Data Privacy into the Spotlight – This is How Healthcare Companies Should Respond

By DAN LINTON Privacy concerns across the country continue to increase, and consumers expect their healthcare information to be private. Headline-making data sales, skepticism of Silicon Valley privacy practices, and COVID-19 contact tracing concerns compounded with a general lack of consumer awareness have continued to generate an ongoing storm ofnegative press and political scrutiny. With COVID-19 continuing to rampage …

COVID-19 is Bringing Data Privacy into the Spotlight – This is How Healthcare Companies Should Respond Read More »

Next wave: how pharma analytics can be improved with new technologies

Pharmaceutical companies have always had access to a steady stream of data to look at what has happened in the past and to try to predict future prescribing trends. Business intelligence (BI) departments have supported this throughout with timely and effective reporting, within an environment that has seen in recent years a bit of an …

Next wave: how pharma analytics can be improved with new technologies Read More »

Brits more comfortable sharing data with pharma since COVID-19 – survey

New research from MHP Health and ComRes looks at what impacts COVID-19 has had on the public’s health data sharing concerns, and asks how the industry can maintain confidence in data usage after the pandemic. In April, at the beginning of the COVID crisis, the Health Secretary Matt Hancock issued a six-month order for the …

Brits more comfortable sharing data with pharma since COVID-19 – survey Read More »

The Dawn of a European Health Data Space – Challenges

The European data strategy aims to construct common data spaces for all, create a single EU market for data, and catalyze a dynamic data economy. In a previous post, we briefly described the essence of the envisioned heath data space and pointed at opportunities and possible starting points to transform this vision into reality. However, …

The Dawn of a European Health Data Space – Challenges Read More »

The Dawn of a European Health Data Space – Opportunities

At the beginning of 2020, the European Commission introduced a “European strategy for data.” The document proposes to bolster and advance the data economy in Europe with a view towards capturing “the benefits of better use of data, including greater productivity and competitive markets, but also improvements in health and well-being, environment, transparent governance and …

The Dawn of a European Health Data Space – Opportunities Read More »

Readying Your Workforce for Digital Transformation

Seeing it as key to innovation and competitive advantage, many businesses in the life sciences are learning to embrace digital transformation these days—in fact, with good reason, most view it as necessary for survival. But whether or not the process of adopting rapidly-evolving digital-age technologies will actually result in business success can really depend on …

Readying Your Workforce for Digital Transformation Read More »

The FAIR Toolkit Helps Researchers with Data Challenges

Since the spread of COVID-19 was first reported, researchers of all types have mobilized to meet the challenges its causative agent, SARS-CoV-2, presents to the world. Data scientists in particular have been quick to apply their expertise to the problems of identifying, tracking and predicting outbreaks; diagnosing COVID-19; identifying infected individuals and detecting non-compliance with …

The FAIR Toolkit Helps Researchers with Data Challenges Read More »